123

UNITE glioblastoma

Understanding and targeting resistance in glioblastoma

We aim to develop concepts to predict and monitor treatment response and failure, and ultimately, to discover novel therapies for glioblastoma patients

More about UNITE
Link to: Research
UNITE Reasearch Header Image

RESEARCH AND WORK PACKAGES

TELL ME MORE
Brain Tumor scaled

UNITE School of Neurooncology

LEARN MORE
Member Teaser Image

MEMBERS

UNITE Glioblastoma brings together physician-scientists and scientists from Heidelberg University Hospital, University Hospital Mannheim, the German Cancer Research Center and Mannheim University of Applied Sciences.

GET TO KNOW ALL MEMBERS

EVENTS

UNITE coordinates regular seminars and symposia with internal and external speakers presenting the latest research findings in glioblastoma research.

FIND OUT ABOUT CURRENT UNITE EVENTS
Event Teaser Image

Participating Institutions

More about

NEWS

All News
header ueber uniteUNITE

IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial

Research findings related to UNITE work packages A03/A06/B01/B03/B06N/C02/C06N The clonal glioma driver mutation IDH1R132H gives rise to a major histocompatibility class II-restricted neoepitope.…
Read more
header ueber uniteUNITE

Felix Sahm named Chied Medical Advisor at Epignostix

Heidelberg Epignostix GmbH has named its co-founder Felix Sahm (A06) as  Chief Medical Advisor, marking an important step in the company’s continued advancement of AI‑enabled DNA‑methylation diagnostics.…
Read more
header ueber uniteUNITE

Stefan Pfister named new Spokesperson of the DKTK

The German Cancer Research Consortium (DKTK) has appointed Stefan Pfister (C01) as its spokesperson for the 2026–2030 funding period. In his new role, he aims to strengthen collaboration across all DKTK…
Read more